Zobrazeno 1 - 10
of 164
pro vyhledávání: '"G Vogelsang"'
Publikováno v:
Water Resources and Economics, 43
Water Resources and Economics 43 (2023)
Water Resources and Economics 43 (2023)
While ongoing climate change requires effective adaptation strategies, decision-making on the scale, timing and location of adaptation measures remains challenging, as the extent and pace of climate change is uncertain. In particular, uncertainty sur
Publikováno v:
Das Gesundheitswesen. 78:37-41
Zur Errichtung eines grenzuberschreitenden Qualitatsverbundes zur Verbesserung der Patientensicherheit in Bezug auf Infektionskrankheiten startete 2009 das Interreg IVa geforderte Projekt „EurSafety Health-Net“. Im Zuge dessen wurden Studien und
Publikováno v:
Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)). 78(1)
In 2009 the project EurSafety Health-Net, funded by Interreg IVa, was initiated in order to create a cross-border quality alliance to enhance patient safety in the field of infectious diseases. Within this framework, several studies and projects addr
Publikováno v:
Equine Veterinary Journal. 17:89-91
Summary Embryo recovery rates from commercial donor mares mated at the clients' farms and commercial and research donors mated at the authors' laboratory were 27, 59 and 57 per cent, respectively. Transfer of embryos recovered on Days 6 to 8 post ovu
Autor:
E G, VOGELSANG
Publikováno v:
Resumenes de trabajos medicos venezolanos. (3)
Autor:
Miriam Freimer, David R. Cornblath, E. Simmons-O’Brien, Vinay Chaudhry, Andrea M. Corse, G. Vogelsang
Publikováno v:
Neurology. 59(12)
Background: Thalidomide is effective for the treatment of some refractory dermatologic and oncologic diseases. Toxic neuropathy limits its use, as embryopathy can be avoided by contraceptive measures. Objective: To describe the clinical, electrophysi
Autor:
S. G. Vogelsang, M. M. Vogelsang
Publikováno v:
Equine Veterinary Journal. 21:71-72
Summary Data were compiled regarding the success of commercial embryo recovery rate, transfer pregnancy rate, and embryonic loss in recipients, with respect to influence of donor parity and age, between 1985 and 1988. There were significant differenc
Autor:
A, Kolbye, K M, Sander Jensen, J, Aldershvile, P B, Hansen, A M, Kjersem, K S, Nielsen, P S, Olsen, B, Rasmussen, G, Vogelsang
Publikováno v:
Ugeskrift for laeger. 162(26)
This economic evaluation was performed to assess the economic consequences for society and for the Danish health care sector of replacing the traditional treatment with Biomedicus assist device with The Mechanical Heart, HeartMate, as a bridge to tra
Autor:
K M, Sander Jensen, J, Aldershvile, S, Boesgaard, P B, Hansen, A M, Kjersem, A, Kolbye, S A, Mortensen, K S, Nielsen, P S, Olsen, B, Rasmussen, G, Vogelsang
Publikováno v:
Ugeskrift for laeger. 162(26)
Treatment with the mechanical heart, HeartMate, has been introduced in Denmark. Short-term circulatory support can be obtained by intraaortic balloon counterpulsation, an external centrifugal pump and the total artificial heart. Long-term circulatory
Autor:
I W, Flinn, J C, Byrd, C, Morrison, J, Jamison, L F, Diehl, T, Murphy, S, Piantadosi, E, Seifter, R F, Ambinder, G, Vogelsang, M R, Grever
Publikováno v:
Blood. 96(1)
To evaluate the response rate and potential toxicities, a phase II trial was conducted of fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated low-grade and select intermediate-grade lymphoid malignancies. Sy